Flexion Therapeutics Raises $9 Million

Flexion Therapeutics, a Woburn, Mass.-based drug development startup, has raised $9 million in new Series A funding from Pfizer's venture capital group. This brings the round total to $42 million, including a previously-announced first close from Versant Ventures, 5AM Ventures and Sofinnova Ventures.

29 January 2010•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail